Lenalidomide in relapsed patients with Multiple Myeloma - Focus on Polyneuropathy

被引：0

作者：

Goldschmidt, H. ^{[1
,2
]}

Heiss, C. ^{[1
,3
]}

Klein, U. ^{[1
]}

Egerer, G. ^{[1
]}

Raab, M. -S. ^{[1
]}

Hillengass, J. ^{[1
]}

Neben, K. ^{[1
]}

机构：

[1] Univ Klinikum Heidelberg, Med Klin, Heidelberg, Germany

[2] Natl Ctr Tumorerkrankungen Heidelberg, Heidelberg, Germany

[3] Deutsch Krebsforschungszentrum, Biostat Abt, D-6900 Heidelberg, Germany

来源：

ONKOLOGIE | 2011年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：158 / 158

页数：1

共 50 条

[41] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
Shin, Junghoon
Lee, Je-Jung
Kim, Kihyun
Min, Chang-Ki
Lee, Jeong-Ok
Suh, Cheolwon
Kim, Jin Seok
Lee, Yoo Jin
Yoon, Sung-Soo
Jo, Jae-Cheol
Lee, Ho Sup
Bang, Soo-Mee
Lee, Jeong-Ok
Bang, Soo-Mee
Lee, Je-Jung
Kim, Kihyun
Min, Chang-Ki
Suh, Cheolwon
Yoon, Dok Hyun
Kim, Jin Seok
Lee, Yoo Jin
Moon, Joon Ho
Yoon, Sung-Soo
Kim, Inho
Jo, Jae-Cheol
Lee, Ho Sup
Park, Seong Kyu
Shin, Ho-Jin
Kim, Min Kyoung
Mun, Yeung-Chul
Lee, Mark Hong
Park, Yong
Eom, Hyeon Seok
Kim, Hyo Jung
Im, Sung Nam
Kim, Sung-Hyun
Do, Young Rok
Lee, Won Sik
Cho, Su-Hee
Yi, Jun Ho
Lee, Jae Hoon
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2019, 109 (01) : 79 - 90
[42] Developing a prediction model for response to lenalidomide treatment in refractory/relapsed multiple myeloma patients
Chung, Y-J.
Yim, S-H.
Jung, S-H.
ANNALS OF ONCOLOGY, 2017, 28
[43] Venous thromboembolism in relapsed or refractory multiple myeloma patients treated with lenalidomide plus dexamethasone
Junghoon Shin
Je-Jung Lee
Kihyun Kim
Chang-Ki Min
Jeong-Ok Lee
Cheolwon Suh
Jin Seok Kim
Yoo Jin Lee
Sung-Soo Yoon
Jae-Cheol Jo
Ho Sup Lee
Soo-Mee Bang
International Journal of Hematology, 2019, 109 : 79 - 90
[44] Lenalidomide is effective for extramedullary disease in relapsed or refractory multiple myeloma
Calvo-Villas, Jose M.
Alegre, Adrian
Calle, Carmen
Hernandez, Miguel T.
Garcia-Sanchez, Ricarda
Ramirez, Gema
EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 87 (03) : 281 - 284
[45] Lenalidomide plus dexamethasone for relapsed multiple myeloma in North America
Weber, Donna M.
Chen, Christine
Niesvizky, Ruben
Wang, Michael
Belch, Andrew
Stadtmauer, Edward A.
Siegel, David
Borrello, Ivan
Rajkumar, S. Vincent
Chanan-Khan, Asher Alban
Lonial, Sagar
Yu, Zhinuan
Patin, John
Olesnyckyj, Marta
Zeldis, Jerome B.
Knight, Robert D.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (21): : 2133 - 2142
[46] Lenalidomide in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma
Palumbo, Antonio
Dimopoulos, Meletios
San Miguel, Jesus
Harousseau, Jean-Luc
Attal, Michel
Hussein, Mohamad
Knop, Stefan
Ludwig, Heinz
von Lilienfeld-Toal, Marie
Sonneveld, Pieter
BLOOD REVIEWS, 2009, 23 (02) : 87 - 93
[47] Outcomes of lenalidomide-based treatment for 57 patients of relapsed or refractory multiple myeloma
邓书会
China Medical Abstracts(Internal Medicine), 2017, 34 (03) : 186 - 186
[48] Lenalidomide Is Effective Treating Patients With Relapsed Multiple Myeloma and Very Severe Renal Impairment
Joao, Cristina M.
Gomes, Fernando
Geraldes, Catarina
Parreira, Joana Maria
Neves, Manuel L.
Coelho, Ines
Esteves, Susana
Esteves, Graca V.
BLOOD, 2013, 122 (21)
[49] Improvement in Overall Survival With Carfilzomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma
Siegel, David S.
Dimopoulos, Meletios A.
Ludwig, Heinz
Facon, Thierry
Goldschmidt, Hartmut
Jakubowiak, Andrzej
San-Miguel, Jesus
Obreja, Mihaela
Blaedel, Julie
Stewart, A. Keith
JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 728 - +
[50] A Phase 1 Trial of Ruxolitinib, Lenalidomide and Methylprednisolone for Relapsed/Refractory Multiple Myeloma Patients
Berenson, James R.
Jennifer, To
Spektor, Tanya M.
Turner, Carley
Swift, Regina
Eades, Benjamin
Schwartz, Gary
Eshaghian, Shahrooz
Stampleman, Laura V.
Moss, Robert A.
Bessudo, Alberto
Patel, Ravindranath
Lim, Stephen
Vescio, Robert
BLOOD, 2018, 132

← 1 2 3 4 5 →